Back
Sarepta Therapeutics Stock Price Chart
This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$59.31
Seasonality Move:
13.2%
7 Day Trial
ALL ACCESS PASS
$
7
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.63 | Buy |
| 20-day SMA: | 59.85 | Sell |
| 50-day SMA: | 85.19 | Sell |
| 200-day SMA: | 118.02 | Sell |
| 8-day EMA: | 54.64 | Buy |
| 20-day EMA: | 61.6 | Sell |
| 50-day EMA: | 79.34 | Sell |
| 200-day EMA: | 107.7 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.43 | Sell |
| Relative Strength Index (14 RSI): | 34.08 | Sell |
| Chaikin Money Flow: | 687151 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.78 - 76.18) | Sell |
| Bollinger Bands (100): | (78.56 - 128.18) | Sell |
Sarepta Therapeutics Technical Analysis
| Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 55.23 while SRPT 8-day simple moving average is 53.63, which is a Buy signal.
-
The stock price of SRPT is 55.23 while Sarepta Therapeutics 20-day SMA is 59.85, which makes it a Sell.
-
Sarepta Therapeutics 50-day simple moving average is 85.19 while SRPT share price is 55.23, making it a Sell technically.
-
SRPT stock price is 55.23 and Sarepta Therapeutics 200-day simple moving average is 118.02, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a BuyThe current Sarepta Therapeutics [SRPT] share price is $55.23. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
5.4B
Price in USD:
55.23
Share Volume:
1.5M
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
48.01
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?The Sarepta Therapeutics stock price is 55.23 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is not overvalued.
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 55.23 while SRPT 8-day exponential moving average is 54.64, which is a Buy signal.
-
The stock price of SRPT is 55.23 while Sarepta Therapeutics 20-day EMA is 61.60, which makes it a Sell.
-
Sarepta Therapeutics 50-day exponential moving average is 79.34 while SRPT share price is 55.23, making it a Sell technically.
-
SRPT stock price is 55.23 and Sarepta Therapeutics 200-day simple moving average is 107.70, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $2.30 per share, a decrease next quarter of $0.53 per share, an increase this year of $4.02 per share, and an increase next year of $5.76 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is -9.43, suggesting Sarepta Therapeutics is a Sell
-
Sarepta Therapeutics Relative Strength Index (RSI) is 34.08, which suggest Sarepta Therapeutics is oversold
-
The Bollinger Bands (25) for Sarepta Therapeutics is (51.78 - 76.18), which suggest Sarepta Therapeutics is a Sell
-
The Bollinger Bands (100) for Sarepta Therapeutics is (78.56 - 128.18), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.